“…Increased activities of MMPs and their tissue inhibitors (TIMPs) have been amply demonstrated in the central nervous system [7,12,13,18,29,[31][32][33][34], myocardium [6,24,25,37], kidney [17] and other tissues [8,42]. In the eye, MMPs were shown to be involved in diseases related to ischemia such as diabetic retinopathy [10,20,26]. The increased activities of MMPs may reflect repair processes following necrosis and apoptosis [37], and their contribution to ischemic damage was recently suggested [17,24,42].…”